Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

China flag China · Delayed Price · Currency is CNY
20.40
+0.55 (2.77%)
Apr 29, 2026, 4:00 PM EDT
16.57%
Market Cap 2.24B
Revenue (ttm) 193.52M
Net Income (ttm) -107.41M
Shares Out 109.93M
EPS (ttm) -0.98
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,368,080
Average Volume 1,254,087
Open 19.86
Previous Close 19.85
Day's Range 19.74 - 20.64
52-Week Range 17.23 - 33.67
Beta 0.96
RSI 48.63
Earnings Date Apr 24, 2026

About Jiangsu CoWin Biotech

Jiangsu CoWin Biotech Co., Ltd. engages in the research and development, production, and sale of biological products in China. The company provides molecular diagnostic raw material enzymes, nucleic acid collection and protection agents, nucleic acid extraction and purification kits, molecular diagnostic testing reagents, etc. It also offers medical device products, nucleic acid collection and protection, PCR, RT-PCR, and qPCR products, molecular diagnosis, isothermal amplification, nucleic acid mass spectrometry, next generation sequencing, nu... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 770
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688426
Full Company Profile

Financial Performance

In 2025, Jiangsu CoWin Biotech's revenue was 193.52 million, an increase of 53.74% compared to the previous year's 125.88 million. Losses were -107.41 million, -31.68% less than in 2024.

Financial Statements

News

There is no news available yet.